158 related articles for article (PubMed ID: 7506452)
1. FK506 versus cyclosporine as primary immunosuppressive agent for orthotopic liver allograft recipients. Histologic and immunopathologic observations.
Hytiroglou P; Lee R; Sharma K; Theise ND; Schwartz M; Miller C; Thung SN
Transplantation; 1993 Dec; 56(6):1389-94. PubMed ID: 7506452
[TBL] [Abstract][Full Text] [Related]
2. Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation.
Platz KP; Mueller AR; Jonas S; Blumhardt G; Bechstein WO; Lobeck H; Neuhaus HL
Clin Transplant; 1995 Jun; 9(3 Pt 1):146-54. PubMed ID: 7549052
[TBL] [Abstract][Full Text] [Related]
3. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
[TBL] [Abstract][Full Text] [Related]
4. Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.
Tsamandas AC; Pham SM; Seaberg EC; Pappo O; Kormos RL; Kawai A; Griffith BP; Zeevi A; Duquesnoy R; Fung JJ; Starzl TE; Demetris AJ
J Heart Lung Transplant; 1997 Jul; 16(7):723-34. PubMed ID: 9257254
[TBL] [Abstract][Full Text] [Related]
5. Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients.
Demetris AJ; Fung JJ; Todo S; McCauley J; Jain A; Takaya S; Alessiani M; Abu-Elmagd K; Van Thiel DH; Starzl TE
Transplantation; 1992 May; 53(5):1056-62. PubMed ID: 1374944
[TBL] [Abstract][Full Text] [Related]
6. The treatment of intractable rejection with tacrolimus (FK506) in pediatric liver transplant recipients.
McDiarmid SV; Wallace P; Vargas J; Ament ME; Busuttil RW
J Pediatr Gastroenterol Nutr; 1995 Apr; 20(3):291-9. PubMed ID: 7541834
[TBL] [Abstract][Full Text] [Related]
7. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial.
McDiarmid SV; Busuttil RW; Ascher NL; Burdick J; D'Alessandro AM; Esquivel C; Kalayoglu M; Klein AS; Marsh JW; Miller CM
Transplantation; 1995 Feb; 59(4):530-6. PubMed ID: 7533345
[TBL] [Abstract][Full Text] [Related]
8. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.
Neuhaus P; Blumhardt G; Bechstein WO; Platz KP; Jonas S; Mueller AR; Langrehr JM; Lohmann R; Schattenfroh N; Knoop M
Transplantation; 1995 Jan; 59(1):31-40. PubMed ID: 7530868
[TBL] [Abstract][Full Text] [Related]
9. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
10. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group.
Solez K; Vincenti F; Filo RS
Transplantation; 1998 Dec; 66(12):1736-40. PubMed ID: 9884269
[TBL] [Abstract][Full Text] [Related]
11. Asymmetric cardiac hypertrophy at autopsy in patients who received FK506 (tacrolimus) or cyclosporine A after liver transplant.
Roberts CA; Stern DL; Radio SJ
Transplantation; 2002 Sep; 74(6):817-21. PubMed ID: 12364862
[TBL] [Abstract][Full Text] [Related]
12. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
[TBL] [Abstract][Full Text] [Related]
13. Morphological findings in non-episode biopsies of kidney transplant allografts treated with FK506 or cyclosporine.
Kyo M; Hatori M; Takahara S; Kyakuno M; Nakamura T; Okada M; Kokado Y; Toki K; Ding XQ; Miki T; Miyamoto M; Okuyama A
Transpl Int; 1998; 11 Suppl 1():S100-3. PubMed ID: 9664955
[TBL] [Abstract][Full Text] [Related]
14. Calcineurin inhibitors and Clostridium difficile infection in adult lung transplant recipients: the effect of cyclosporine versus tacrolimus.
Lee JT; Whitson BA; Kelly RF; D'Cunha J; Dunitz JM; Hertz MI; Shumway SJ
J Surg Res; 2013 Sep; 184(1):599-604. PubMed ID: 23566442
[TBL] [Abstract][Full Text] [Related]
15. FK506 conversion for intractable rejection of the liver allograft.
McDiarmid SV; Klintmalm GB; Busuttil RW
Transpl Int; 1993; 6(6):305-12. PubMed ID: 7507675
[TBL] [Abstract][Full Text] [Related]
16. Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506.
Platz KP; Mueller AR; Blumhardt G; Bachmann S; Bechstein WO; Kahl A; Neuhaus P
Transplantation; 1994 Jul; 58(2):170-8. PubMed ID: 7518975
[TBL] [Abstract][Full Text] [Related]
17. Changes in the expression of major histocompatibility complex class II antigens in liver allograft rejection.
Hubscher SG; Adams DH; Elias E
J Pathol; 1990 Oct; 162(2):165-71. PubMed ID: 2250195
[TBL] [Abstract][Full Text] [Related]
18. Occurrence of gammopathies and lymphoproliferative disorders in liver transplant recipients randomized to tacrolimus (FK506)- or cyclosporine-based immunosuppression.
Pham H; Lemoine A; Salvucci M; Azoulay D; Frenoy N; Samuel D; Reynès M; Bismuth H; Debuire B
Liver Transpl Surg; 1998 Mar; 4(2):146-51. PubMed ID: 9516567
[TBL] [Abstract][Full Text] [Related]
19. Combined transplantation of small and large bowel. FK506 versus cyclosporine A in a porcine model.
Pirenne J; Benedetti E; Gruessner A; Moon C; Hakim N; Fryer JP; Troppmann C; Nakhleh RE; Gruessner RW
Transplantation; 1996 Jun; 61(12):1685-94. PubMed ID: 8685944
[TBL] [Abstract][Full Text] [Related]
20. Plasma cell-rich acute renal allograft rejection.
Charney DA; Nadasdy T; Lo AW; Racusen LC
Transplantation; 1999 Sep; 68(6):791-7. PubMed ID: 10515379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
